VarCT Diagnostics is engaged in the design and development of novel technology for capturing and analysis of circulating tumor cells of diverse origin, ultimately aiming for methods that will allow early screening and detection of all types of cancer
VarCT DIAGNOSTICS is a privately held biotechnology company founded in Copenhagen, Denmark, 2017 as a subsidiary to VAR2 Pharmaceuticals
The technology is based on groundbreaking discoveries made by researchers at University of Copenhagen, Denmark, in collaboration with partners at University of British Columbia, Canada.
VarCT Diagnostics/VAR2 Pharmaceuticals will be at the Nordic Life Science Days in Stockholm 10-12 September 2018. We look forward to meet old and new partners in the Life Science business.
Check out the article about VarCT Diagnostics and VAR2 Pharmaceuticals (in Danish) here.
